Cite
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3.
MLA
Henderson, Lauren A., et al. “American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3.” Arthritis & Rheumatology (Hoboken, N.J.), vol. 74, no. 4, Apr. 2022, pp. e1–20. EBSCOhost, https://doi.org/10.1002/art.42062.
APA
Henderson, L. A., Canna, S. W., Friedman, K. G., Gorelik, M., Lapidus, S. K., Bassiri, H., Behrens, E. M., Kernan, K. F., Schulert, G. S., Seo, P., Son, M. B. F., Tremoulet, A. H., VanderPluym, C., Yeung, R. S. M., Mudano, A. S., Turner, A. S., Karp, D. R., & Mehta, J. J. (2022). American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis & Rheumatology (Hoboken, N.J.), 74(4), e1–e20. https://doi.org/10.1002/art.42062
Chicago
Henderson, Lauren A, Scott W Canna, Kevin G Friedman, Mark Gorelik, Sivia K Lapidus, Hamid Bassiri, Edward M Behrens, et al. 2022. “American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3.” Arthritis & Rheumatology (Hoboken, N.J.) 74 (4): e1–20. doi:10.1002/art.42062.